Chi‐Fei Huang

2.3k citations
14 papers · 1.2k indexed · h-index 12
Topics
Acute Myeloid Leukemia Research (10 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers)RNA modifications and cancer (3 papers)
Partner nations
TaiwanUnited States

In The Last Decade

Chi‐Fei Huang

14 papers receiving 1.1k citations

Peers

Chi‐Fei Huang
Comparison fields: 5 of 75
  • Hematology 898
  • Molecular Biology 635
  • Genetics 404
  • Cancer Research 200
  • Public Health, Environmental and Occupational Health 141
Replace Esperanza Such with:
Esperanza Such Spain
Naomi Park United Kingdom
John Bognacki United States
HC Hoagland United States
Timo Siitonen Finland
Varsha Bhakta Canada
Yasushi Shimonaka United States
Johan Billiet Belgium
Carlos Román Spain
Shahrbano Rostami Iran
Chi‐Fei Huang relative to Esperanza Such Spain Esperanza Such's profile →
Citations per field
00.5×1.5×1.8×
Esperanza Such · 1×
Citations per year

Countries citing papers authored by Chi‐Fei Huang

Since Specialization
Citations

This map shows the geographic impact of Chi‐Fei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Fei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Fei Huang more than expected).

Fields of papers citing papers by Chi‐Fei Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Fei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Fei Huang. The network helps show where Chi‐Fei Huang may publish in the future.

Co-authorship network of co-authors of Chi‐Fei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Fei Huang. A scholar is included among the top collaborators of Chi‐Fei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Fei Huang. Chi‐Fei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2 27
3 48
4 109
5 163
6 111
7 153
8 14
9 240
10 47
11 47
12 4
13 115
14 76

About Chi‐Fei Huang

Chi‐Fei Huang is a scholar working on Hematology, Genetics and Oral Surgery, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Hematology (898 citations), Genetics (404 citations) and Cancer Research (200 citations). Chi‐Fei Huang has collaborated with scholars based in Taiwan and United States. Frequent co-authors include Wen‐Chien Chou, Chien‐Yuan Chen, Hwei‐Fang Tien, Jih‐Luh Tang, Mei‐Hsuan Tseng, Ming Yao, Woei Tsay, Shang‐Ju Wu, Hsin‐An Hou and Fen‐Yu Lee. Their work appears in journals such as Blood, Cancer Research and Journal of The Electrochemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026